A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.

International journal of nanomedicine

Volumn 6, Issue , 2011, Pages 2123-2131

  Cheng, Jian ^a   Wang, Jun ^b   Chen, Baoan ^b   Xia, Guohua ^b   Cai, Xiaohui ^b   Liu, Ran ^b   Ren, Yanyan ^b   Bao, Wen ^b   Wang, Xuemei ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLISOQUINOLINE DERIVATIVE; BROMOTETRANDRINE; DAUNORUBICIN; DRUG CARRIER; GLYCOPROTEIN P; MAGNETITE NANOPARTICLE;

ANALYSIS OF VARIANCE; ARTICLE; CELL STRAIN K 562; CHEMISTRY; DOSE RESPONSE; DRUG RESISTANCE; FLUORESCENCE MICROSCOPY; HUMAN; LEUKEMIA; METABOLISM; MULTIDRUG RESISTANCE;

ANALYSIS OF VARIANCE; BENZYLISOQUINOLINES; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; K562 CELLS; LEUKEMIA; MAGNETITE NANOPARTICLES; MICROSCOPY, FLUORESCENCE; P-GLYCOPROTEIN;

EID: 84864311996     PISSN: None     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (0)